From: Clinical guidelines in pediatric headache: evaluation of quality using the AGREE II instrument
Guideline reference | Year | Diagnosis and/or treatment | Population | Domain 1 | Domain 2 | Domain 3 | Domain 4 | Domain 5 | Domain 6 | Overall quality score (range 1-7) (M ± SD) | Overall assessment usage recommendations (n = 11)* |
---|---|---|---|---|---|---|---|---|---|---|---|
Scope and purpose % | Stakeholder involvement % | Rigor of development % | Clarity and presentation % | Applicability % | Editorial indipendence % | ||||||
Lewis[21] | 2002 | Diagnosis | Children and adolescents | 82.3 | 53 | 72.9 | 82.8 | 48.9 | 53 | 5.45 ± 1.13 | SR = 8 (72.7%); R = 2 (18.2%) NR = 1 (9.1%) |
SISC[22] | 2003 | Diagnosis and treatment | Children and adolescents | 67.2 | 81.3 | 57.8 | 64.1 | 43.6 | 41.7 | 4.73 ± 1.49 | SR = 3 (27.3%); R =5 (45.4%) NR = 3 (27.3%) |
Lewis[23] | 2004 | Treatment | Children and adolescents | 79.8 | 49 | 68.4 | 77.3 | 44.7 | 61.4 | 5.36 ± 0.81 | SR = 5 (45.4%); R = 6 (54.6%) |
Geraud[24] | 2004 | Diagnosis and treatment | Adult and children | 60.6 | 55 | 42.8 | 67.2 | 31.4 | 56.8 | 4.18 ± 1.08 | SR = 1 (9.1%); R = 5 (45.4%) NR = 5 (45.4%) |
Bendtsen[25] | 2012 | Diagnosis and treatment | Adult and children | 62.6 | 56.1 | 37.5 | 65.7 | 36 | 68.9 | 4.18 ± 1.54 | SR =5 (45.4%); R =1 (9.1%) NR = 5 (45.4%) |
NICE[26] | 2012 | Diagnosis and treatment | Adult and young people | 92.9 | 86.4 | 90.7 | 94.9 | 75.4 | 74.2 | 6.54 ± 0.69 | SR = 8 (72.7%); R = 3 (27.3%) |